HEADER IMMUNE SYSTEM 25-JAN-17 5MY4 TITLE STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C#17 IN COMPLEX WITH TITLE 2 HUMAN ABETA-PE3-12PEGB COMPND MOL_ID: 1; COMPND 2 MOLECULE: FAB C#17 LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: FAB C#17 HEAVY CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: PYROGLUTAMATE-ABETA PE3-12-PEGB; COMPND 11 CHAIN: C; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_TAXID: 10090; SOURCE 4 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 8 ORGANISM_TAXID: 10090; SOURCE 9 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 11 MOL_ID: 3; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_TAXID: 9606 KEYWDS ALZHEIMER'S DISEASE, PYROGLUTAMATE ABETA, MONOCLONAL ANTIBODY, KEYWDS 2 FIBRILLATION, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR C.PARTHIER,A.PIECHOTTA,M.T.STUBBS REVDAT 4 11-MAR-20 5MY4 1 SEQRES REVDAT 3 11-OCT-17 5MY4 1 REMARK REVDAT 2 09-AUG-17 5MY4 1 JRNL REVDAT 1 28-JUN-17 5MY4 0 JRNL AUTH A.PIECHOTTA,C.PARTHIER,M.KLEINSCHMIDT,K.GNOTH,T.PILLOT, JRNL AUTH 2 I.LUES,H.U.DEMUTH,S.SCHILLING,J.U.RAHFELD,M.T.STUBBS JRNL TITL STRUCTURAL AND FUNCTIONAL ANALYSES OF JRNL TITL 2 PYROGLUTAMATE-AMYLOID-BETA-SPECIFIC ANTIBODIES AS A BASIS JRNL TITL 3 FOR ALZHEIMER IMMUNOTHERAPY. JRNL REF J. BIOL. CHEM. V. 292 12713 2017 JRNL REFN ESSN 1083-351X JRNL PMID 28623233 JRNL DOI 10.1074/JBC.M117.777839 REMARK 2 REMARK 2 RESOLUTION. 2.21 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.21 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.85 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.200 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 40700 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 2042 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.8549 - 5.4420 0.99 2636 138 0.1756 0.2434 REMARK 3 2 5.4420 - 4.3241 0.99 2654 140 0.1421 0.1773 REMARK 3 3 4.3241 - 3.7789 1.00 2655 142 0.1545 0.1874 REMARK 3 4 3.7789 - 3.4340 0.99 2640 141 0.1681 0.2255 REMARK 3 5 3.4340 - 3.1882 1.00 2672 141 0.1779 0.2540 REMARK 3 6 3.1882 - 3.0004 1.00 2626 141 0.1888 0.2581 REMARK 3 7 3.0004 - 2.8503 1.00 2622 138 0.2131 0.2850 REMARK 3 8 2.8503 - 2.7263 1.00 2680 139 0.2118 0.3133 REMARK 3 9 2.7263 - 2.6214 1.00 2663 137 0.2123 0.2751 REMARK 3 10 2.6214 - 2.5310 1.00 2639 138 0.2150 0.2839 REMARK 3 11 2.5310 - 2.4519 1.00 2684 143 0.2181 0.2724 REMARK 3 12 2.4519 - 2.3819 1.00 2649 140 0.2305 0.3481 REMARK 3 13 2.3819 - 2.3192 0.97 2598 139 0.2248 0.3360 REMARK 3 14 2.3192 - 2.2626 0.92 2424 129 0.2267 0.2920 REMARK 3 15 2.2626 - 2.2112 0.68 1816 96 0.2414 0.3298 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.030 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3463 REMARK 3 ANGLE : 0.988 4716 REMARK 3 CHIRALITY : 0.055 527 REMARK 3 PLANARITY : 0.006 600 REMARK 3 DIHEDRAL : 7.725 2048 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5MY4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1200003220. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-FEB-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40703 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.210 REMARK 200 RESOLUTION RANGE LOW (A) : 28.852 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 8.868 REMARK 200 R MERGE (I) : 0.08700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.8400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.21 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.36 REMARK 200 R MERGE FOR SHELL (I) : 0.25900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.550 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.3.0 REMARK 200 STARTING MODEL: 2DQT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% W/V PEG 3350, 100 MM BIS-TRIS, 200 REMARK 280 MM MAGNESIUM CHLORIDE, 0.5% N-DODECYL-BETA-D-MALTOSIDE, PH 5.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 286K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 43.57100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4600 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A 219 REMARK 465 CYS B 137 REMARK 465 GLY B 138 REMARK 465 ASP B 139 REMARK 465 THR B 140 REMARK 465 THR B 141 REMARK 465 GLY B 223 REMARK 465 PRO B 224 REMARK 465 ILE B 225 REMARK 465 SER B 226 REMARK 465 THR B 227 REMARK 465 ILE B 228 REMARK 465 ASN B 229 REMARK 465 PRO B 230 REMARK 465 CYS B 231 REMARK 465 GLY C 7 REMARK 465 TYR C 8 REMARK 465 GLU C 9 REMARK 465 VAL C 10 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN B 114 O HOH B 301 2.13 REMARK 500 OD2 ASP A 115 NZ LYS A 204 2.15 REMARK 500 O HOH A 326 O HOH A 394 2.18 REMARK 500 OE1 GLU B 1 O HOH B 302 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NH1 ARG A 82 O PHE B 68 2555 2.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 56 -50.95 71.97 REMARK 500 ARG A 82 82.03 -152.81 REMARK 500 ASN B 103 -99.74 -142.74 REMARK 500 SER B 158 108.25 -55.69 REMARK 500 SER B 169 -45.27 -151.69 REMARK 500 REMARK 500 REMARK: NULL DBREF 5MY4 A 1 219 PDB 5MY4 5MY4 1 219 DBREF 5MY4 B 1 231 PDB 5MY4 5MY4 1 231 DBREF 5MY4 C 1 10 PDB 5MY4 5MY4 1 10 SEQRES 1 A 219 ASP VAL VAL MET THR GLN THR PRO LEU SER LEU PRO VAL SEQRES 2 A 219 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 A 219 GLN SER LEU VAL HIS SER ASP GLY ASN THR TYR LEU HIS SEQRES 4 A 219 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO LYS LEU LEU SEQRES 5 A 219 ILE TYR LYS VAL SER ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 A 219 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 A 219 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 A 219 PHE CYS SER GLN SER THR HIS VAL PRO PRO THR PHE GLY SEQRES 9 A 219 GLY GLY THR LYS LEU GLU ILE LYS ARG ALA ASP ALA ALA SEQRES 10 A 219 PRO THR VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU SEQRES 11 A 219 THR SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN SEQRES 12 A 219 PHE TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP SEQRES 13 A 219 GLY SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR SEQRES 14 A 219 ASP GLN ASP SER LYS ASP SER THR TYR SER MET SER SER SEQRES 15 A 219 THR LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SEQRES 16 A 219 SER TYR THR CYS GLU ALA THR HIS LYS THR SER THR SER SEQRES 17 A 219 PRO ILE VAL LYS SER PHE ASN ARG ASN GLU CYS SEQRES 1 B 231 GLU VAL LYS LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 B 231 PRO GLY GLY SER ARG LYS LEU SER CYS ALA ALA SER GLY SEQRES 3 B 231 PHE THR PHE SER ASP TYR GLY MET ALA TRP VAL ARG GLN SEQRES 4 B 231 ALA PRO GLY LYS GLY PRO GLU TRP VAL ALA PHE ILE SER SEQRES 5 B 231 ASN LEU ALA TYR SER ILE TYR TYR ALA ASP THR VAL THR SEQRES 6 B 231 GLY ARG PHE THR ILE SER ARG GLU ASN ALA LYS ASN THR SEQRES 7 B 231 LEU TYR LEU GLU MET SER SER LEU ARG SER GLU ASP THR SEQRES 8 B 231 ALA MET TYR TYR CYS ALA ARG TYR ASP TYR ASP ASN ILE SEQRES 9 B 231 LEU ASP TYR VAL MET ASP TYR TRP GLY GLN GLY THR SER SEQRES 10 B 231 VAL THR VAL SER SER ALA LYS THR THR PRO PRO SER VAL SEQRES 11 B 231 TYR PRO LEU ALA PRO GLY CYS GLY ASP THR THR GLY SER SEQRES 12 B 231 SER VAL THR LEU GLY CYS LEU VAL LYS GLY TYR PHE PRO SEQRES 13 B 231 GLU SER VAL THR VAL THR TRP ASN SER GLY SER LEU SER SEQRES 14 B 231 SER SER VAL HIS THR PHE PRO ALA LEU LEU GLN SER GLY SEQRES 15 B 231 LEU TYR THR MET SER SER SER VAL THR VAL PRO SER SER SEQRES 16 B 231 THR TRP PRO SER GLN THR VAL THR CYS SER VAL ALA HIS SEQRES 17 B 231 PRO ALA SER SER THR THR VAL ASP LYS LYS LEU GLU PRO SEQRES 18 B 231 SER GLY PRO ILE SER THR ILE ASN PRO CYS SEQRES 1 C 10 PCA PHE ARG HIS ASP SER GLY TYR GLU VAL HET PCA C 1 8 HETNAM PCA PYROGLUTAMIC ACID FORMUL 3 PCA C5 H7 N O3 FORMUL 4 HOH *191(H2 O) HELIX 1 AA1 GLU A 84 LEU A 88 5 5 HELIX 2 AA2 SER A 126 GLY A 133 1 8 HELIX 3 AA3 LYS A 188 GLU A 192 1 5 HELIX 4 AA4 THR B 28 TYR B 32 5 5 HELIX 5 AA5 ASN B 74 LYS B 76 5 3 HELIX 6 AA6 ARG B 87 THR B 91 5 5 HELIX 7 AA7 SER B 165 SER B 167 5 3 SHEET 1 AA1 4 MET A 4 THR A 7 0 SHEET 2 AA1 4 ALA A 19 SER A 25 -1 O ARG A 24 N THR A 5 SHEET 3 AA1 4 ASP A 75 ILE A 80 -1 O PHE A 76 N CYS A 23 SHEET 4 AA1 4 PHE A 67 SER A 72 -1 N SER A 68 O LYS A 79 SHEET 1 AA2 6 SER A 10 VAL A 13 0 SHEET 2 AA2 6 THR A 107 ILE A 111 1 O LYS A 108 N LEU A 11 SHEET 3 AA2 6 GLY A 89 GLN A 95 -1 N GLY A 89 O LEU A 109 SHEET 4 AA2 6 LEU A 38 GLN A 43 -1 N TYR A 41 O PHE A 92 SHEET 5 AA2 6 PRO A 49 TYR A 54 -1 O LEU A 52 N TRP A 40 SHEET 6 AA2 6 ASN A 58 ARG A 59 -1 O ASN A 58 N TYR A 54 SHEET 1 AA3 4 SER A 10 VAL A 13 0 SHEET 2 AA3 4 THR A 107 ILE A 111 1 O LYS A 108 N LEU A 11 SHEET 3 AA3 4 GLY A 89 GLN A 95 -1 N GLY A 89 O LEU A 109 SHEET 4 AA3 4 THR A 102 PHE A 103 -1 O THR A 102 N GLN A 95 SHEET 1 AA4 4 THR A 119 PHE A 123 0 SHEET 2 AA4 4 GLY A 134 PHE A 144 -1 O VAL A 138 N PHE A 123 SHEET 3 AA4 4 TYR A 178 THR A 187 -1 O LEU A 184 N VAL A 137 SHEET 4 AA4 4 VAL A 164 TRP A 168 -1 N SER A 167 O SER A 181 SHEET 1 AA5 4 SER A 158 ARG A 160 0 SHEET 2 AA5 4 ASN A 150 ILE A 155 -1 N ILE A 155 O SER A 158 SHEET 3 AA5 4 SER A 196 THR A 202 -1 O GLU A 200 N LYS A 152 SHEET 4 AA5 4 ILE A 210 ASN A 215 -1 O LYS A 212 N CYS A 199 SHEET 1 AA6 4 LYS B 3 SER B 7 0 SHEET 2 AA6 4 ARG B 18 SER B 25 -1 O ALA B 23 N VAL B 5 SHEET 3 AA6 4 THR B 78 MET B 83 -1 O LEU B 81 N LEU B 20 SHEET 4 AA6 4 PHE B 68 GLU B 73 -1 N SER B 71 O TYR B 80 SHEET 1 AA7 6 GLY B 10 VAL B 12 0 SHEET 2 AA7 6 THR B 116 VAL B 120 1 O THR B 119 N VAL B 12 SHEET 3 AA7 6 ALA B 92 TYR B 101 -1 N ALA B 92 O VAL B 118 SHEET 4 AA7 6 MET B 34 GLN B 39 -1 N VAL B 37 O TYR B 95 SHEET 5 AA7 6 GLU B 46 ILE B 51 -1 O VAL B 48 N TRP B 36 SHEET 6 AA7 6 ILE B 58 TYR B 60 -1 O TYR B 59 N PHE B 50 SHEET 1 AA8 5 GLY B 10 VAL B 12 0 SHEET 2 AA8 5 THR B 116 VAL B 120 1 O THR B 119 N VAL B 12 SHEET 3 AA8 5 ALA B 92 TYR B 101 -1 N ALA B 92 O VAL B 118 SHEET 4 AA8 5 LEU B 105 TRP B 112 -1 O VAL B 108 N ASP B 100 SHEET 5 AA8 5 PHE C 2 ARG C 3 -1 O PHE C 2 N ASP B 106 SHEET 1 AA9 4 SER B 129 LEU B 133 0 SHEET 2 AA9 4 SER B 144 TYR B 154 -1 O LEU B 150 N TYR B 131 SHEET 3 AA9 4 LEU B 183 PRO B 193 -1 O TYR B 184 N TYR B 154 SHEET 4 AA9 4 VAL B 172 GLN B 180 -1 N PHE B 175 O SER B 187 SHEET 1 AB1 3 THR B 160 TRP B 163 0 SHEET 2 AB1 3 THR B 203 HIS B 208 -1 O SER B 205 N THR B 162 SHEET 3 AB1 3 THR B 213 LYS B 218 -1 O THR B 213 N HIS B 208 SSBOND 1 CYS A 23 CYS A 93 1555 1555 2.10 SSBOND 2 CYS A 139 CYS A 199 1555 1555 2.06 SSBOND 3 CYS B 22 CYS B 96 1555 1555 2.04 SSBOND 4 CYS B 149 CYS B 204 1555 1555 2.06 LINK C PCA C 1 N PHE C 2 1555 1555 1.33 CISPEP 1 THR A 7 PRO A 8 0 -5.91 CISPEP 2 VAL A 99 PRO A 100 0 -0.83 CISPEP 3 TYR A 145 PRO A 146 0 -1.03 CISPEP 4 PHE B 155 PRO B 156 0 -3.79 CISPEP 5 TRP B 197 PRO B 198 0 -1.13 CRYST1 43.170 87.142 58.029 90.00 96.06 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023164 0.000000 0.002458 0.00000 SCALE2 0.000000 0.011476 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017330 0.00000 MASTER 278 0 1 7 44 0 0 6 0 0 0 36 END